The document contains disclosures related to portfolio holdings, including estimated annual figures, reinvestment details, option disclosures, foreign currency transactions, and proxy voting. It also includes a schedule of realized gains and losses for the current period, specifically detailing a transaction involving Bristol Myers Squibb.
doj/DataSet10/EFTA01371959.pdf
{"document_type":"tabular","document_subtype":"financial statement","key_organizations":["Pershing LLC","The Bank of New York Mellon Corporation","Options Clearing Corporation"],"reference_numbers":["Account Number AD10061"]}